Author

L. Humeau

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Ecology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:DNA methylation· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1

Frequent Co-Authors

D. B. Weiner· 2 shared K. Broderick· 2 shared A. Jaeger· 1 shared A. Moore· 1 shared A. Patella· 1 shared B. Wang· 1 shared C. Feare· 1 shared C. Iffland· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

D. B. Weiner

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Migratory patterns of two major influenza virus host species on tropical islands

C. Lebarbenchon, S. Boucher, C. Feare, M. Dietrich, C. Larose, L. Humeau, M. Le Corre, A. Jaeger

This study investigates migratory patterns of brown and lesser noddies on tropical islands and their role in avian influenza virus transmission.

bioRxiv · Jan 18, 2023 · PreprintEcology

Comparison of Wild Type DNA Sequence of Spike Protein from SARS-CoV-2 with Optimized Sequence on The Induction of Protective Responses Against SARS-Cov-2 Challenge in Mouse Model

S. Jiang, S. Wu, G. Zhao, Y. He, L. Bao, J. Liu, C. Qin, J. Hou, Y. Ding, J. Wu, J. Yan, L. Humeau, A. Patella, D. B. Weiner, K. Broderick, B. Wang

This study compares a wild-type SARS-CoV-2 spike protein DNA vaccine with an optimized sequence in a mouse model, showing enhanced immune responses and protection against viral challenge.

bioRxiv · Aug 13, 2021Immunology

Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drive rapid and potent immunogenicity capable of single-dose protection

K. Konrath, K. Liaw, Y. Wu, X. Zhu, S. Walker, Z. Xu, K. Schultheis, N. Chokkalingam, N. J. Tursi, J. Du, M. Sullivan, M. Purwar, A. Moore, V. Machado, I. Maricic, , D. W. Kulp

This study develops glycan-modified SARS-CoV-2 nanoparticle vaccines that induce potent neutralizing antibodies and single-dose protection against SARS-CoV-2 in multiple animal models.

bioRxiv · Apr 28, 2021Immunology